Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bot...
FDA Recall #D-0160-2023 — Class III — November 9, 2022
Product Description
Triamterene and Hydrochlorothiazide Capsules, USP (37.5 mg/25 mg), Rx Only, 1000 Capsules per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 0527-1632-10
Reason for Recall
Failed Impurity/Degradation Specifications
Recalling Firm
Lannett Company Inc. — Seymour, IN
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
5,640 bottles
Distribution
Nationwide USA
Code Information
Lots: 20256318A (12/2022), 20256321A (12/2022), 21000238A (01/2023)
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated